Georgia joins the Centre as a Contributing Investigator, bringing expertise in oncogenic viral biology.
CIDRI-Africa biostatistician Olina Ngwenya adapts by transitioning to online R workshops.
The projects cover a range of topics from treatment trials to diagnostics to serological analyses and answer several critical questions about the virus, the disease, and the pandemic.
Today two years have passed since the tragic loss of Prof. Bongani Mayosi, Dean of the University of Cape Town’s (UCT) Faculty of Health Sciences, remarkable scholar, CIDRI-Africa Principal Investigator, colleague, and friend.
Investigators at the University of Cape Town (UCT) are working with the South African National Blood Service (SANBS) and the Western Cape Blood Service (WCBS) to conduct the PROTECT-patient trial.
The HIATUS study, a research programme being launched by the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) at the University of Cape Town (UCT), will investigate the interaction between the COVID-19 pandemic and common endemic infectious diseases in the South African context.
The grant will enable CIDRI-Africa to further deepen our researcher community as public engagement champions, engage local communities and stakeholders, and raise awareness of research results.
TB: Scientists know a great deal, but there’s still more to learn
The pair have joined the Centre as Contributing Investigators.
Clinical Research Platform Academic Sean Wasserman was awarded the Stephen Lawn TB-HIV Research Leadership Prize at the 50th Union World Conference on Lung Health in Hyderabad, India.
Two University of Cape Town research groups participated in a study that examined how well a new tuberculosis vaccine works in adults.
Incorporating nuanced consent into genomic research practices is possible and necessary.
+27 (0)21 406 6797
Institute of Infectious Disease
and Molecular Medicine
University of Cape Town
Supported by the Wellcome Trust (203135/Z/16/Z)